MCM2 and Carbonic Anhydrase 9 Are Novel Potential Targets for Neuroblastoma Pharmacological Treatment

To overcome the lack of effective pharmacological treatments for high-risk neuroblastoma (HR-NB), the development of novel in vitro and in vivo models that better recapitulate the disease is required. Here, we used an in vitro multiclonal cell model encompassing NB cell differentiation stages, to id...

Descripción completa

Detalles Bibliográficos
Autores principales: Garbati, Patrizia, Barbieri, Raffaella, Cangelosi, Davide, Zanon, Carlo, Costa, Delfina, Eva, Alessandra, Thellung, Stefano, Calderoni, Matilde, Baldini, Francesca, Tonini, Gian Paolo, Modesto, Paola, Florio, Tullio, Pagano, Aldo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692293/
https://www.ncbi.nlm.nih.gov/pubmed/33153038
http://dx.doi.org/10.3390/biomedicines8110471

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692293/
https://www.ncbi.nlm.nih.gov/pubmed/33153038
http://dx.doi.org/10.3390/biomedicines8110471

Ejemplares similares